NCT06041516 2026-03-27A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting70 enrolled